首頁
NinePoint Medical

7月 2026NinePoint Medical的市場佔有率分析

健康 > 健康 - 其他

域名ninepointmedical.com

成立年份2009

僱員51 - 200

年度營收$15M - $25M

NinePoint Medical

NinePoint Medical（包含公司地區）

ninepointmedical.com

查看更多網站流量與參與度資訊

NinePoint Medical截至 7月 2026 的總收入為 15M - 25M

NinePoint Medical 熱門網域產生的總收入

NinePoint Medical 熱門網域 3 年內的總收入

NinePoint Medical 熱門網域的總收入

ninepointmedical.com15M - 25M

透過銷售情報查看更多內容

NinePoint Medical的熱門網域總造訪量

了解NinePoint Medical市場觸達率與潛在市場影響力。

過去 3 個月的訪問總量

子公司細目

ninepointmedical.com--

透過銷售情報查看更多內容

NinePoint Medical的熱門網域平均造訪時長

分析NinePoint Medical參與度指標。

過去 3 個月平均造訪時長

子公司細目

ninepointmedical.com--

透過銷售情報查看更多內容

NinePoint Medical的熱門網域平均頁面瀏覽量

了解NinePoint Medical如何保持使用者的參與度、培養其興趣，並鼓勵他們採取下一步。

過去 3 個月平均頁面瀏覽量

子公司細目

ninepointmedical.com--

透過銷售情報查看更多內容

NinePoint Medical按網域劃分的熱門競爭對手

7月 2026的熱門類似網站，依相似度排名

infraredx.com公司名Infraredx僱員51 - 200總部美國, 馬薩諸塞州, Bedford年度營收$25M - $50M訪問總量2.2K健康 > 健康 - 其他

使用的熱門技術NinePoint Medical

这些是NinePoint Medical顶级域名使用的行业网站技术

內容管理系統 (4)

WordPress

音訊視訊媒體 (2)

Vimeo

轉換與分析 (2)

Google Analytics

電子郵件服務 (2)

G Suite

更多技術

6

檢視所有

新聞與訊號來自NinePoint Medical

透過 Similarweb 銷售訊號提醒，每當目標受眾出現新的機會或威脅時，你就會收到每日更新的已識別購買訊號。

新聞NinePoint Medical, Inc. launches NvisionVLE platform.NinePoint Medical launched the NvisionVLE platform in 2013, having switched its focus from Raman technology to OCT in light of advances then being made in OCT by the Wellman Center for Photomedicine.

新聞NinePoint Medical, Inc. hires Eman as Vice President of Research and Development.Eman joined NinePoint Medical during its inception in 2010 as a technical co-founder and has served as the Vice President of Research and Development for the past four-years.

新聞NinePoint Medical, Inc. hired Eman Namati as president and chief executive officer on Jul 1st '18.NinePoint Medical, Inc, a transformative medical device company pioneering the use of Optical Coherence Tomography (OCT) for gastrointestinal applications, is pleased to announce the appointment of Eman Namati, Ph.D., to President and Chief Executive Officer.